Literature DB >> 34989845

Automated quantitative lesion water uptake in acute stroke is a predictor of malignant cerebral edema.

JiaQian Shi1, Hang Wu2, Zheng Dong1, XianXian Liang1, QuanHui Liu3, Wusheng Zhu2, ChangSheng Zhou3, MengJie Lu3, Jia Liu3, XiaoQin Su3, GuangMing Lu4,5, XiaoQing Cheng6.   

Abstract

OBJECTIVES: Net water uptake (NWU) has been shown to have a linear relationship with brain edema. Based on an automated-Alberta Stroke Program Early Computed Tomography Score (ASPECTS) technique, we automatically derived NWU from baseline multimodal computed tomography (CT), namely ASPECTS-NWU. We aimed to determine if ASPECTS-NWU can predict the development of malignant cerebral edema (MCE).
METHODS: One hundred and forty-six patients with large-vessel occlusion were retrospectively enrolled. Quantitative NWU based on automated-ASPECTS was measured both on nonenhanced CT (NECT) and CT angiography (CTA), namely NECT-ASPECT-NWU and CTA-ASPECTS-NWU. The correlation between ASPECTS-NWU and cerebral edema (CED) grades was calculated using Spearman rank correlation. Univariate logistic regression was used to assess the effect of radiological and clinical features on MCE, and a multivariable model with significant factors from the univariate regression analysis was built. Receiver operating characteristic (ROC) was obtained and area under curve (AUC) was compared.
RESULTS: CTA-ASPECTS-NWU had a moderate positive correlation with CED grades (r = 0.62; 95% confidence interval [CI], 0.51-0.71; p < 0.001). The CTA-ASPECTS-NWU performed better than the NECT-ASPECTS-NWU with AUC: 0.88 vs. 0.71 (p < 0.001). Multivariable logistic regression model integrating CTA-ASPECTS-NWU, collateral score, and age showed the CTA-ASPECTS-NWU was an independent predictor of MCE with an AUC of 0.94 (95% CI: 0.90-0.98; p < 0.001).
CONCLUSIONS: This study demonstrates that ASPECTS-NWU is a quantitative predictor of MCE after large-vessel occlusion of the middle cerebral artery territory. The multivariable logistic regression model may enhance the identification of patients with MCE needing anti-edematous treatment. KEY POINTS: • The automated-ASPECTS technique can automatically detect the affected regions with early ischemic changes and NWU could be manually calculated. • The CTA-ASPECTS-NWU performs better than the NECT-ASPECTS-NWU on predicting the development of MCE. • The multivariable logistic regression model may enhance the identification of patients with MCE needing anti-edematous treatment.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Brain edema; Computed tomography angiography; Diagnosis, computer-assisted; Ischemic stroke

Mesh:

Substances:

Year:  2022        PMID: 34989845     DOI: 10.1007/s00330-021-08443-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  2 in total

1.  Interobserver agreement between senior radiology resident, neuroradiology fellow, and experienced neuroradiologist in the rating of Alberta Stroke Program Early Computed Tomography Score (ASPECTS).

Authors:  Chai Kobkitsuksakul; Oranan Tritanon; Vichan Suraratdecha
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

2.  Elevated early lesion water uptake in acute stroke predicts poor outcome despite successful recanalization - When "tissue clock" and "time clock" are desynchronized.

Authors:  Jawed Nawabi; Fabian Flottmann; Andre Kemmling; Helge Kniep; Hannes Leischner; Peter Sporns; Gerhard Schön; Uta Hanning; Götz Thomalla; Jens Fiehler; Gabriel Broocks
Journal:  Int J Stroke       Date:  2019-10-26       Impact factor: 5.266

  2 in total
  1 in total

1.  Net water uptake, a neuroimaging marker of early brain edema, as a predictor of symptomatic intracranial hemorrhage after acute ischemic stroke.

Authors:  Tianqi Xu; Jianhong Yang; Qing Han; Yuefei Wu; Xiang Gao; Yao Xu; Yi Huang; Aiju Wang; Mark W Parsons; Longting Lin
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.